Description:

ODM derived from http://clinicaltrials.gov/show/NCT00624338

Link:

http://clinicaltrials.gov/show/NCT00624338

Keywords:
Versions (1) ▾
  1. 12/10/13
Uploaded on:

December 10, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00624338 Systemic Lupus Erythematosus, SLE

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age at least 16 Years
Disease history of at least six months meeting at least 4 ACR criteria for SLE
BILAG flare A or B at screening requiring a change in corticosteroids
a positive ANA or anti-dsDNA at screening
Female subjects must be willing to avoid pregnancy
Exclusion Criteria
Active moderate to severe glomerulonephritis (kidney impairment)
Active central nervous system SLE deemed to be severe/progressive
Previous treatment with rituximab, abatacept, or belimumab
History of demyelinating disease or optic neuritis